JPRN-jRCT2031200378招募中未知
Special Drug Use Observational Study of Xolair in Patients With Severe to Most Severe Seasonal Allergic Rhinitis Aged >=12 Years and < 18 Years Whose Symptoms Were Inadequately Controlled Despite to Conventional Therapies
Sugimoto Toshiya0 个研究点目标入组 30 人开始时间: 2021年3月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- >= 12age old 至 <= 17age old（—）
- 性别
- All
入选标准
- •1.Patients who used Xolair in accordance with the instructions of package insert
- •2. Patients aged >= 12 years and < 18 years at the start of Xolair
- •3. Patients who used Xolair for the following indication:
- •Indication: seasonal allergic rhinitis (only patients with severe to most severe symptoms whose symptoms were inadequately controlled despite to conventional therapies)
- •4. Patients having provided written consent to participate in this study before the start of Xolair in the relevant pollen season, in person and from their legally acceptable representative (legal representative)
排除标准
- •Patients with a history of hypersensitivity to any of the Xolair ingredients
研究者
相似试验
已完成
不适用
Special Drug Use Observational Study of Xolair in Patients With Severe to Most Severe Seasonal Allergic Rhinitis Aged ≥ 12 Years and < 18 Years Whose Symptoms Were Inadequately Controlled Despite to Conventional TherapiesAllergic RhinitisNCT04648930Novartis Pharmaceuticals50
招募中
不适用
Pharmacokinetic evaluation of long-term Xolair-therapy in severe asthma patientsAllergic AsthmaNL-OMON25198Medical Centre Leeuwarden30
已完成
Unknown
Special Drug Use-Results Survey of Onoacttachyarrhythmia, atrial fibrillation/atrial flutter in patients with cardiac dysfunctionJPRN-jRCT1080222572ONO PHARMACEUTICAL CO., LTD.800
尚未招募
不适用
XOFLUZA Specified Drug Use-results Survey (prophylaxis use for type B influenza virus)Prophylaxis for influenza virus infectionJPRN-UMIN000045811Shionogi & Co., Ltd.480
已完成
不适用
XELODA Special Drug Use Surveillance, XELOX as adjuvant chemotherapy for colon cancercolon cancerJPRN-UMIN000016446Chugai Pharmaceutical Co. Ltd.40